Affiliation:
1. Interventional Psychiatry Program, St. Michael’s Hospital, Toronto,
Ontario, Canada
2. Department of Biostatistics, Dalla Lana School of Public Health,
University of Toronto, Toronto, Ontario, Canada
3. Department of Psychiatry, University of Toronto, Toronto, Ontario,
Canada
Abstract
Abstract
Introduction The relationship between antidepressant use and class with
cognition in depression is unclear. This study aimed to evaluate the association
of cognition with depressive symptoms and antidepressant use (class, duration,
number).
Methods Data from the National Health and Nutrition Examination Survey
were examined for cognitive function through various tests and memory issues
through the Medical Conditions questionnaire. Depressive symptoms were assessed
using the Patient Health Questionnaire-9.
Results A total of 2867 participants were included. Participants with
depressive symptoms had significantly higher odds of cognitive impairment (CI)
on the animal fluency test (aOR=1.89, 95% CI=1.30, 2.73, P=0.002) and Digit
Symbol Substitution test (aOR=2.58, 95% CI=1.34, 4.9, P=0.007), as well as
subjective memory issues (aOR=7.25, 95% CI=4.26, 12.32, P<0.001) than those
without depression. There were no statistically significant associations between
any of the CI categories and depressive symptoms treated with an antidepressant
and antidepressant use duration. Participants who were using more than one
antidepressant had significantly higher odds of subjective memory issues than
those who were using one antidepressant. Specifically, users of atypical
antidepressants, selective serotonin reuptake inhibitors, or tricyclic
antidepressants (TCAs) had significantly higher odds of subjective memory issues
in comparison to no antidepressants, with TCAs showing the largest odds
(aOR=4.21, 95% CI=1.19, 14.86, P=0.028).
Discussion This study highlights the relationship between depressive
symptoms, antidepressant use, and CI. Future studies should further evaluate the
mechanism underlying this phenomenon.